公开(公告)号：US20190183914A1

公开(公告)日：2019-06-20

申请号：US16246084

申请日：2019-01-11

Applicant: THERAPIX BIOSCIENCES LTD.

Inventor： Ephraim Brener ,  Elran Haber ,  Adi Zuloff-Shani ,  Ascher Shmulewitz

IPC: A61K31/7036 ,  A61K31/43 ,  A61K31/353 ,  A61K31/065 ,  A61K31/16 ,  A61P31/04

CPC classification number: A61K31/7036 ,  A61K31/065 ,  A61K31/16 ,  A61K31/352 ,  A61K31/353 ,  A61K31/43 ,  A61K31/546 ,  A61P31/04 ,  Y02A50/473 ,  A61K2300/00

Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.

公开(公告)号：US20210093652A1

公开(公告)日：2021-04-01

申请号：US16896701

申请日：2020-06-09

Applicant: THERAPIX BIOSCIENCES LTD.

Inventor： Ephraim Brener ,  Elran Haber ,  Adi Zuloff-Shani ,  Ascher Shmulewitz

IPC: A61K31/7036 ,  A61K31/16 ,  A61K31/43 ,  A61K31/352 ,  A61K31/546 ,  A61P31/04 ,  A61K31/065 ,  A61K31/353

Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.

公开(公告)号：US20200038367A1

公开(公告)日：2020-02-06

申请号：US16598029

申请日：2019-10-10

Applicant: THERAPIX BIOSCIENCES, LTD.

Inventor： Ephraim Brener ,  Elran Haber ,  Ascher Shmulewitz

IPC: A61K31/352 ,  A61K45/06 ,  A61P25/30 ,  A61P25/14 ,  A61P25/00 ,  A61P29/00 ,  A61K31/164 ,  A61K36/185

Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.

公开(公告)号：US20200030281A1

公开(公告)日：2020-01-30

申请号：US16589611

申请日：2019-10-01

Applicant: THERAPIX BIOSCIENCES, LTD.

Inventor： Ephraim Brener ,  Elran Haber ,  Ascher Shmulewitz

IPC: A61K31/352 ,  A61K45/06 ,  A61P25/30 ,  A61P25/14 ,  A61P25/00 ,  A61P29/00 ,  A61K31/164 ,  A61K36/185

Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.

公开(公告)号：US20200022946A1

公开(公告)日：2020-01-23

申请号：US16557379

申请日：2019-08-30

Applicant: THERAPIX BIOSCIENCES, LTD.

Inventor： Ephraim Brener ,  Elran Haber ,  Ascher Shmulewitz

IPC: A61K31/352 ,  A61K36/185 ,  A61K31/164 ,  A61P29/00 ,  A61P25/00 ,  A61P25/14 ,  A61P25/30 ,  A61K45/06

Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.